C
AbbVie Inc. ABBV
$210.60 $1.100.53% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -27.06% 5,945.45% -101.41% 13.94% 0.07%
Total Depreciation and Amortization 0.54% -3.00% 1.11% -2.44% 2.75%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 206.40% -83.41% 407.57% -50.88% 514.86%
Change in Net Operating Assets 78.22% -549.87% -152.93% 122.18% -1,469.23%
Cash from Operations 215.17% -76.80% 29.39% 139.85% -43.79%
Capital Expenditure -14.47% 19.24% -16.87% -3.32% -24.87%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -74.72% 69.98% 78.90% -907.47% 91.02%
Divestitures -- -- -- -- --
Other Investing Activities -26.32% -81.82% -57.00% 2,800.00% -200.00%
Cash from Investing -60.68% 60.78% 77.30% -649.18% 88.51%
Total Debt Issued -29.07% 179.35% -- -- -100.00%
Total Debt Repaid -24.06% 47.48% -1,329.78% 87.96% 34.46%
Issuance of Common Stock -91.07% 460.00% -85.07% 570.00% -92.13%
Repurchase of Common Stock 98.75% -168.44% -2,005.88% -88.89% 99.32%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid 0.51% -6.29% -0.04% -0.04% 0.79%
Other Financing Activities -118.18% 1,000.00% -96.88% -- 100.00%
Cash from Financing -115.42% 81.66% -123.34% 49.61% -156.35%
Foreign Exchange rate Adjustments 233.33% 119.57% -675.00% 188.89% 50.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 470.20% 79.86% 70.49% -18.96% -193.98%